Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2006

Open Access 01-12-2006 | Research

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells

Authors: Oumar Camara, Andreas Kavallaris, Helmut Nöschel, Matthias Rengsberger, Cornelia Jörke, Katharina Pachmann

Published in: World Journal of Surgical Oncology | Issue 1/2006

Login to get access

Abstract

Background

Surgery of malignant tumors has long been suspected to be the reason for enhancement of growth of metastases with fatal outcome. This often prevented surgeons from touching the tumor if not absolutely necessary. We have shown in lung cancer patients that surgery, itself, leads to mobilization of tumor cells into peripheral blood. Some of the mobilized cells finding an appropriate niche might grow to form early metastases. Monitoring of tumor cell release during and the fate of such cells after surgery for breast cancer may help to reveal how metastases develop after surgery.

Method

We used the MAINTRAC® analysis, a new tool for online observation of circulating epithelial cells, to monitor the number of epithelial cells before, 30 min, 60 min, three and seven days after surgery and during subsequent variable follow up in breast cancer patients.

Results

Circulating epithelial cells were already present before surgery in all patients. During the first 30–60 min after surgery values did not change immediately. They started increasing during the following 3 to 4 days up to thousand fold in 85% of treated patients in spite of complete resection of the tumor with tumor free margins in all patients. There was a subsequent re-decrease, with cell numbers remaining above pre-surgery values in 58% of cases until onset of chemotherapy. In a few cases, where no further therapy or only hormone treatment was given due to low risk stage, cell numbers were monitored for up to three years. They remained elevated with no or a slow decrease over time. This was in contrast to the observation in a patient where surgery was performed for benign condition. She was monitored before surgery with no cells detectable. Epithelial cells increased up to more than 50 000 after surgery but followed by a complete reduction to below the threshold of detection.

Conclusion

Frequently before but regularly during surgery of breast cancer, epithelial cells are mobilized into circulation. Part of these cells, most probably normal or apoptotic cells, are cleared from the circulation as also shown to occur in benign conditions. After resection even if complete and of small tumors, cells can remain in the circulation over long times. Such cells may remain "dormant" but might settle and grow into metastases, if they find appropriate conditions, even after years.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bonadonna G, Moliterni A, Zambetti M, Daidone MG, Pilotti S, Gianni L, Valagussa P: 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ. 2005, 330: 217-220. 10.1136/bmj.38314.622095.8F.PubMedCentralCrossRefPubMed Bonadonna G, Moliterni A, Zambetti M, Daidone MG, Pilotti S, Gianni L, Valagussa P: 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ. 2005, 330: 217-220. 10.1136/bmj.38314.622095.8F.PubMedCentralCrossRefPubMed
2.
go back to reference Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA: From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. PNAS. 2003, 100: 7737-7742. 10.1073/pnas.1331931100.PubMedCentralCrossRefPubMed Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA: From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. PNAS. 2003, 100: 7737-7742. 10.1073/pnas.1331931100.PubMedCentralCrossRefPubMed
3.
go back to reference Pachmann K, Camara O, Kavallaris A, Schneider U, Schünemann S, Höffken K: Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res. 2005, 7: R975-R979. 10.1186/bcr1328.PubMedCentralCrossRefPubMed Pachmann K, Camara O, Kavallaris A, Schneider U, Schünemann S, Höffken K: Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res. 2005, 7: R975-R979. 10.1186/bcr1328.PubMedCentralCrossRefPubMed
4.
go back to reference Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004, 10: 8152-8162. 10.1158/1078-0432.CCR-04-1110.CrossRefPubMed Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004, 10: 8152-8162. 10.1158/1078-0432.CCR-04-1110.CrossRefPubMed
5.
go back to reference Pachmann K: Long-time recirculating tumor cells in breast cancer patients. Clin Cancer Res. 2005, 11: 5657-5658. 10.1158/1078-0432.CCR-05-0191.CrossRefPubMed Pachmann K: Long-time recirculating tumor cells in breast cancer patients. Clin Cancer Res. 2005, 11: 5657-5658. 10.1158/1078-0432.CCR-05-0191.CrossRefPubMed
6.
go back to reference Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G: Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005, 16: 1449-1457. 10.1093/annonc/mdi280.CrossRefPubMed Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G: Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005, 16: 1449-1457. 10.1093/annonc/mdi280.CrossRefPubMed
7.
go back to reference Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K: The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer. 2005, 103: 884-891. 10.1002/cncr.20834.CrossRefPubMed Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K: The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer. 2005, 103: 884-891. 10.1002/cncr.20834.CrossRefPubMed
8.
go back to reference Braun S, Marth C: Circulating tumor cells in metastatic breast cancer-toward individualized treatment?. N Engl J Med. 2004, 351: 824-826. 10.1056/NEJMe048163.CrossRefPubMed Braun S, Marth C: Circulating tumor cells in metastatic breast cancer-toward individualized treatment?. N Engl J Med. 2004, 351: 824-826. 10.1056/NEJMe048163.CrossRefPubMed
9.
go back to reference Pachmann K, Heiss P, Demel U, Tilz G: Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC). Clin Chem Lab Med. 2001, 39: 811-817. 10.1515/CCLM.2001.134.CrossRefPubMed Pachmann K, Heiss P, Demel U, Tilz G: Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC). Clin Chem Lab Med. 2001, 39: 811-817. 10.1515/CCLM.2001.134.CrossRefPubMed
10.
go back to reference Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, Pachmann U, Höffken K: Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med. 2005, 43: 617-627. 10.1515/CCLM.2005.107.CrossRefPubMed Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, Pachmann U, Höffken K: Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med. 2005, 43: 617-627. 10.1515/CCLM.2005.107.CrossRefPubMed
11.
go back to reference Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, Chambers AF: Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 2003, 82: 199-206. 10.1023/B:BREA.0000004377.12288.3c.CrossRefPubMed Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, Chambers AF: Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 2003, 82: 199-206. 10.1023/B:BREA.0000004377.12288.3c.CrossRefPubMed
12.
go back to reference Baines CJ: Are there downsides to mammography screening?. Breast J. 2005, 11 (Suppl 1): 7-10. 10.1111/j.1075-122X.2005.217162.x.CrossRef Baines CJ: Are there downsides to mammography screening?. Breast J. 2005, 11 (Suppl 1): 7-10. 10.1111/j.1075-122X.2005.217162.x.CrossRef
13.
go back to reference Cserni G, Bianchi S, Boecker W, Decker T, Lacerda M, Rank F, Wells CA, European Working Group for Breast Screening Pathology: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005, 103: 358-367. 10.1002/cncr.20760.CrossRefPubMed Cserni G, Bianchi S, Boecker W, Decker T, Lacerda M, Rank F, Wells CA, European Working Group for Breast Screening Pathology: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005, 103: 358-367. 10.1002/cncr.20760.CrossRefPubMed
14.
go back to reference Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, Sharma A, Jakub JW, Cantor A, Centeno BA, Dupont E, Muro-Cacho C, Nicosia S: Benign Mechanical Transport of Breast Epithelial Cells to Sentinel Lymph Nodes. Am J Surg Pathol. 2004, 28: 1641-1645.CrossRefPubMed Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, Sharma A, Jakub JW, Cantor A, Centeno BA, Dupont E, Muro-Cacho C, Nicosia S: Benign Mechanical Transport of Breast Epithelial Cells to Sentinel Lymph Nodes. Am J Surg Pathol. 2004, 28: 1641-1645.CrossRefPubMed
15.
go back to reference Naumov GN, Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J, Almog N: A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst. 2006, 98: 316-325.CrossRefPubMed Naumov GN, Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J, Almog N: A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst. 2006, 98: 316-325.CrossRefPubMed
16.
go back to reference van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 2005, 65: 4698-4706. 10.1158/0008-5472.CAN-04-4126.CrossRefPubMed van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 2005, 65: 4698-4706. 10.1158/0008-5472.CAN-04-4126.CrossRefPubMed
17.
go back to reference Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK: Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 2004, 64: 7336-7345. 10.1158/0008-5472.CAN-04-0113.CrossRefPubMed Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK: Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 2004, 64: 7336-7345. 10.1158/0008-5472.CAN-04-0113.CrossRefPubMed
18.
go back to reference Chambers AF, George N, Naumov GN, Vantyghem SA, Tuck AB: Molecular biology of breast metastasis: Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res. 2000, 2: 400-407. 10.1186/bcr86.PubMedCentralCrossRefPubMed Chambers AF, George N, Naumov GN, Vantyghem SA, Tuck AB: Molecular biology of breast metastasis: Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res. 2000, 2: 400-407. 10.1186/bcr86.PubMedCentralCrossRefPubMed
19.
go back to reference Rolle A, Günzel R, Pachmann U, Willen B, Höffken K, Pachmann K: Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitore by MAINTRAC® is a predictor for relapse: A preliminary report. World J Surg Oncol. 2005, 3: 18-10.1186/1477-7819-3-18.PubMedCentralCrossRefPubMed Rolle A, Günzel R, Pachmann U, Willen B, Höffken K, Pachmann K: Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitore by MAINTRAC® is a predictor for relapse: A preliminary report. World J Surg Oncol. 2005, 3: 18-10.1186/1477-7819-3-18.PubMedCentralCrossRefPubMed
20.
go back to reference Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C, Polzer B, Petronio M, Eils R, Klein CA: Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell. 2005, 8: 227-239. 10.1016/j.ccr.2005.08.003.CrossRefPubMed Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C, Polzer B, Petronio M, Eils R, Klein CA: Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell. 2005, 8: 227-239. 10.1016/j.ccr.2005.08.003.CrossRefPubMed
21.
go back to reference Singletary SE: New approaches to surgery for breast cancer. Endocr Relat Cancer. 2001, 8: 265-286. 10.1677/erc.0.0080265.CrossRefPubMed Singletary SE: New approaches to surgery for breast cancer. Endocr Relat Cancer. 2001, 8: 265-286. 10.1677/erc.0.0080265.CrossRefPubMed
22.
go back to reference Engel J, Eckel R, Kerr J, Schmidt M, Furstenberger G, Richter R, Sauer H, Senn HJ, Holzel D: The process of metastasisation for breast cancer. Eur J Cancer. 2003, 39: 1794-1806. 10.1016/S0959-8049(03)00422-2.CrossRefPubMed Engel J, Eckel R, Kerr J, Schmidt M, Furstenberger G, Richter R, Sauer H, Senn HJ, Holzel D: The process of metastasisation for breast cancer. Eur J Cancer. 2003, 39: 1794-1806. 10.1016/S0959-8049(03)00422-2.CrossRefPubMed
23.
go back to reference Retsky MW, Swartzendruber DE, Bame PD, Wardwell RH: Computer model challenges breast cancer treatment strategy. Cancer Invest. 1994, 12: 559-567.CrossRefPubMed Retsky MW, Swartzendruber DE, Bame PD, Wardwell RH: Computer model challenges breast cancer treatment strategy. Cancer Invest. 1994, 12: 559-567.CrossRefPubMed
Metadata
Title
Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells
Authors
Oumar Camara
Andreas Kavallaris
Helmut Nöschel
Matthias Rengsberger
Cornelia Jörke
Katharina Pachmann
Publication date
01-12-2006
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2006
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-4-67

Other articles of this Issue 1/2006

World Journal of Surgical Oncology 1/2006 Go to the issue